Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > INSM Insmed > Detailed Quotes

INSM Insmed

Watchlist
18.460
-0.170-0.91%
Close  12/09 16:00 ET
19.280
+0.820+4.44%
Post Mkt Price 12/09 16:57 ET
High
18.830
Open
18.830
Turnover
14.95M
Low
18.375
Pre Close
18.630
Volume
807.34K
Market Cap
2.50B
P/E(TTM)
Loss
52wk High
28.940
Shares
135.48M
P/E(Static)
Loss
52wk Low
16.410
Float Cap
2.48B
Bid/Ask %
0.00%
Historical High
797.500
Shs Float
134.24M
Volume Ratio
0.74
Historical Low
2.640
Dividend TTM
--
Div Yield TTM
--
P/B
-83.53
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.60%
Amplitude
2.44%
Avg Price
18.520
Lot Size
1
Float Cap
2.48B
Bid/Ask %
0.00%
Historical High
797.500
Shs Float
134.24M
Volume Ratio
0.74
Historical Low
2.640
Dividend TTM
--
P/B
-83.53
Dividend LFY
--
Turnover Ratio
0.60%
Amplitude
2.44%
Avg Price
18.520
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.
CEO: Mr. William H. Lewis
Market: NASDAQ
Listing Date: 06/01/2000
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist